MedTrace Logo

The Effectiveness of Robotic Assisted Gait Training as an Adjunct to Traditional Physiotherapy in Cerebral Palsy

NCT04960683 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2022-03-25

No results posted yet for this study

Summary

Need for study

There are a few studies published on this topic from various parts of the globe and the results are mixed. Hence further research is required in this area and none of the studies have included samples from the Middle East.

Some studies done in this area focus on biomechanical aspects of gait (Cherni, 2018) and our study mainly focuses on functional aspects of gait and quality of life.

Studies done on this area focus highly on gait components and very little is available on the literature on improving balance. Since balance and stability are crucial for walking, it was decided to exclusively assess balance.

Due to a wide range of therapeutic benefits, it is paramount to evaluate the effectiveness of different therapies provided to improve gait.

Aim of the study:

The aim of the proposed research is to investigate the effectiveness of robotic assisted gait training using Lokomat device as an adjunct in improving gait, balance and quality of life in children with cerebral palsy.

Conditions

  • Cerebral Palsy

Interventions

DEVICE

Lokomat training

Control group will receive the routine conventional physiotherapy treatment and the treatment for this group consists of the following: Conventional therapy protocol: * 5 sessions of 45 minutes a week, each session includes: * 5 minutes of stretching exercise * 20 minutes of strengthening exercise * 10 minutes of balance exercise * 10 minutes of gait training Experimental group will receive 45 min of Lokomat in addition to the conventional approach (as explained above). Since Lokomat appointments can be only 8 per day, it is planned to have two groups of 8 participants for 4 weeks each. The Lokomat training include the following: * 5 sessions of 45 minutes of conventional therapy (same as above) per week * 5 sessions of 45 minutes on Lokomat per week

Sponsors & Collaborators

  • Fatima College of Health Sciences

    lead OTHER

Principal Investigators

  • Dragana Djuric · FCHS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-08
Primary Completion
2021-07-31
Completion
2021-12-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04960683 on ClinicalTrials.gov